Isu Abxis Co Stock Fundamentals
| 086890 Stock | KRW 4,660 140.00 2.92% |
ISU Abxis Co fundamentals help investors to digest information that contributes to ISU Abxis' financial success or failures. It also enables traders to predict the movement of ISU Stock. The fundamental analysis module provides a way to measure ISU Abxis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ISU Abxis stock.
ISU |
ISU Abxis Co Company Current Valuation Analysis
ISU Abxis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ISU Abxis Current Valuation | 365.33 B |
Most of ISU Abxis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ISU Abxis Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ISU Abxis Co has a Current Valuation of 365.33 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.
ISU Abxis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ISU Abxis's current stock value. Our valuation model uses many indicators to compare ISU Abxis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ISU Abxis competition to find correlations between indicators driving ISU Abxis's intrinsic value. More Info.ISU Abxis Co is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ISU Abxis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ISU Abxis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.ISU Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ISU Abxis' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ISU Abxis could also be used in its relative valuation, which is a method of valuing ISU Abxis by comparing valuation metrics of similar companies.ISU Abxis is rated below average in current valuation category among its peers.
ISU Fundamentals
| Return On Equity | 0.49 | |||
| Return On Asset | -0.0463 | |||
| Profit Margin | (0.57) % | |||
| Operating Margin | (0.30) % | |||
| Current Valuation | 365.33 B | |||
| Shares Outstanding | 26.63 M | |||
| Shares Owned By Insiders | 33.85 % | |||
| Shares Owned By Institutions | 0.19 % | |||
| Price To Sales | 5.25 X | |||
| Revenue | 28.02 B | |||
| Gross Profit | 11.07 B | |||
| EBITDA | (3.78 B) | |||
| Net Income | 829.93 M | |||
| Cash And Equivalents | 14.35 B | |||
| Cash Per Share | 326.65 X | |||
| Total Debt | 24.02 B | |||
| Debt To Equity | 2.60 % | |||
| Current Ratio | 7.09 X | |||
| Book Value Per Share | 2,322 X | |||
| Cash Flow From Operations | (5.84 B) | |||
| Target Price | 15000.0 | |||
| Number Of Employees | 16 | |||
| Beta | 1.49 | |||
| Market Capitalization | 179.72 B | |||
| Total Asset | 151.09 B | |||
| Retained Earnings | (42.73 B) | |||
| Working Capital | 28.98 B | |||
| Current Asset | 43.93 B | |||
| Current Liabilities | 14.95 B | |||
| Z Score | 4.2 | |||
| Net Asset | 151.09 B |
About ISU Abxis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ISU Abxis Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ISU Abxis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ISU Abxis Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea. ISU ABXIS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with ISU Abxis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ISU Abxis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISU Abxis will appreciate offsetting losses from the drop in the long position's value.Moving together with ISU Stock
| 0.7 | 207940 | Samsung Biologics | PairCorr |
| 0.64 | 302440 | SK Bioscience | PairCorr |
| 0.69 | 326030 | Sk Biopharmaceuticals | PairCorr |
| 0.69 | 298380 | ABL Bio | PairCorr |
| 0.96 | 144510 | Green Cross Lab | PairCorr |
Moving against ISU Stock
The ability to find closely correlated positions to ISU Abxis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ISU Abxis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ISU Abxis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ISU Abxis Co to buy it.
The correlation of ISU Abxis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ISU Abxis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ISU Abxis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ISU Abxis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ISU Stock
ISU Abxis financial ratios help investors to determine whether ISU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ISU with respect to the benefits of owning ISU Abxis security.